Oral Solid Dosage Pharmaceutical Formulation Market to 2027 - Global Analysis and Forecasts By Dosage Form (Tablets, Capsules, Powders, Others); Drug Release Mechanism (Immediate Release, Extended Release, Others); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Drug Stores, Online Pharmacy); and Geography
Report Code: TIPRE00006929 No. of Pages: 150 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
Oral solid dosage pharmaceutical formulation is the primary procedure for the drug manufacturing companies. The solid form of the medicine is the easy way to consume the right dosage for various chronic and acute diseases. Formulating oral dosage form of medicine is cost effective and easy to manufacture and hence offer significant benefits to the manufacturers.
MARKET DYNAMICS
The oral solid dosage pharmaceutical formulation market is anticipated to grow in the forecast, owing to the factors such as increasing prevalence of diseases, advantages owing to the use of oral drugs, advances and innovations in the drugs, and easy availability of the drugs. The market is expected to have growth opportunities due to rising incidences of the chronic and acute diseases. Also, the growing generic pharmaceutical is likely to enhance the growth of the market.
MARKET SCOPE
The "Global Oral Solid Dosage Pharmaceutical Formulation Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of oral solid dosage pharmaceutical formulation market with detailed market segmentation by dosage form, drug release mechanism, distribution channel and geography. The global oral solid dosage pharmaceutical formulation market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading oral solid dosage pharmaceutical formulation market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global oral solid dosage pharmaceutical formulation market is segmented on the basis of dosage form, drug release mechanism and distribution channel. Based on dosage the market is segmented into tablets, capsules, powders, and others. Based on drug release mechanism the market is segmented into immediate release, extended release, and others. Based on distribution channel the market is segmented into hospital pharmacy, retail pharmacy, drug stores, and online pharmacy.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global oral solid dosage pharmaceutical formulation market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The oral solid dosage pharmaceutical formulation market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting oral solid dosage pharmaceutical formulation market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Oral solid dosage pharmaceutical formulation market in these regions.
The reports cover key developments in the oral solid dosage pharmaceutical formulation market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from oral solid dosage pharmaceutical formulation market are anticipated to lucrative growth opportunities in the future with the rising demand for oral solid dosage pharmaceutical formulation market in the global market. Below mentioned is the list of few companies engaged in the oral solid dosage pharmaceutical formulation market.
The report also includes the profiles of oral solid dosage pharmaceutical formulation market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Oral solid dosage pharmaceutical formulation is the primary procedure for the drug manufacturing companies. The solid form of the medicine is the easy way to consume the right dosage for various chronic and acute diseases. Formulating oral dosage form of medicine is cost effective and easy to manufacture and hence offer significant benefits to the manufacturers.
MARKET DYNAMICS
The oral solid dosage pharmaceutical formulation market is anticipated to grow in the forecast, owing to the factors such as increasing prevalence of diseases, advantages owing to the use of oral drugs, advances and innovations in the drugs, and easy availability of the drugs. The market is expected to have growth opportunities due to rising incidences of the chronic and acute diseases. Also, the growing generic pharmaceutical is likely to enhance the growth of the market.
MARKET SCOPE
The "Global Oral Solid Dosage Pharmaceutical Formulation Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of oral solid dosage pharmaceutical formulation market with detailed market segmentation by dosage form, drug release mechanism, distribution channel and geography. The global oral solid dosage pharmaceutical formulation market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading oral solid dosage pharmaceutical formulation market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global oral solid dosage pharmaceutical formulation market is segmented on the basis of dosage form, drug release mechanism and distribution channel. Based on dosage the market is segmented into tablets, capsules, powders, and others. Based on drug release mechanism the market is segmented into immediate release, extended release, and others. Based on distribution channel the market is segmented into hospital pharmacy, retail pharmacy, drug stores, and online pharmacy.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global oral solid dosage pharmaceutical formulation market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The oral solid dosage pharmaceutical formulation market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting oral solid dosage pharmaceutical formulation market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Oral solid dosage pharmaceutical formulation market in these regions.
The reports cover key developments in the oral solid dosage pharmaceutical formulation market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from oral solid dosage pharmaceutical formulation market are anticipated to lucrative growth opportunities in the future with the rising demand for oral solid dosage pharmaceutical formulation market in the global market. Below mentioned is the list of few companies engaged in the oral solid dosage pharmaceutical formulation market.
The report also includes the profiles of oral solid dosage pharmaceutical formulation market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Merck Co and Inc.
- Novartis AG
- Pfizer Inc
- Bayer AG
- Astellas Pharma Inc
- Takeda Pharmaceutical Company Limited
- Ashland
- CordenPharma International
- Acme Generics LLP
- COREALIS Pharma Inc
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Oral Solid Dosage Pharmaceutical Formulation Market - By Dosage Form
1.3.2 Oral Solid Dosage Pharmaceutical Formulation Market - By Drug Release Mechanism
1.3.3 Oral Solid Dosage Pharmaceutical Formulation Market - By Distribution Channel
1.3.4 Oral Solid Dosage Pharmaceutical Formulation Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKET - GLOBAL MARKET ANALYSIS
6.1. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION - GLOBAL MARKET OVERVIEW
6.2. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKET - REVENUE AND FORECASTS TO 2027 - DOSAGE FORM
7.1. OVERVIEW
7.2. DOSAGE FORM MARKET FORECASTS AND ANALYSIS
7.3. TABLETS
7.3.1. Overview
7.3.2. Tablets Market Forecast and Analysis
7.4. CAPSULES
7.4.1. Overview
7.4.2. Capsules Market Forecast and Analysis
7.5. POWDERS
7.5.1. Overview
7.5.2. Powders Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKET - REVENUE AND FORECASTS TO 2027 - DRUG RELEASE MECHANISM
8.1. OVERVIEW
8.2. DRUG RELEASE MECHANISM MARKET FORECASTS AND ANALYSIS
8.3. IMMEDIATE RELEASE
8.3.1. Overview
8.3.2. Immediate Release Market Forecast and Analysis
8.4. EXTENDED RELEASE
8.4.1. Overview
8.4.2. Extended Release Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACY
9.3.1. Overview
9.3.2. Hospital Pharmacy Market Forecast and Analysis
9.4. RETAIL PHARMACY
9.4.1. Overview
9.4.2. Retail Pharmacy Market Forecast and Analysis
9.5. DRUG STORES
9.5.1. Overview
9.5.2. Drug Stores Market Forecast and Analysis
9.6. ONLINE PHARMACY.
9.6.1. Overview
9.6.2. Online Pharmacy. Market Forecast and Analysis
10. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Oral Solid Dosage Pharmaceutical Formulation Market Overview
10.1.2 North America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis
10.1.3 North America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Dosage Form
10.1.4 North America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Drug Release Mechanism
10.1.5 North America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Countries
10.1.6.1 United States Oral Solid Dosage Pharmaceutical Formulation Market
10.1.6.1.1 United States Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.1.6.1.2 United States Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.1.6.1.3 United States Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.1.6.2 Canada Oral Solid Dosage Pharmaceutical Formulation Market
10.1.6.2.1 Canada Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.1.6.2.2 Canada Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.1.6.2.3 Canada Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.1.6.3 Mexico Oral Solid Dosage Pharmaceutical Formulation Market
10.1.6.3.1 Mexico Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.1.6.3.2 Mexico Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.1.6.3.3 Mexico Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Oral Solid Dosage Pharmaceutical Formulation Market Overview
10.2.2 Europe Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis
10.2.3 Europe Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Dosage Form
10.2.4 Europe Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Drug Release Mechanism
10.2.5 Europe Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Oral Solid Dosage Pharmaceutical Formulation Market
10.2.6.1.1 Germany Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.2.6.1.2 Germany Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.2.6.1.3 Germany Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.2.6.2 France Oral Solid Dosage Pharmaceutical Formulation Market
10.2.6.2.1 France Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.2.6.2.2 France Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.2.6.2.3 France Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.2.6.3 Italy Oral Solid Dosage Pharmaceutical Formulation Market
10.2.6.3.1 Italy Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.2.6.3.2 Italy Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.2.6.3.3 Italy Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.2.6.4 Spain Oral Solid Dosage Pharmaceutical Formulation Market
10.2.6.4.1 Spain Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.2.6.4.2 Spain Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.2.6.4.3 Spain Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.2.6.5 United Kingdom Oral Solid Dosage Pharmaceutical Formulation Market
10.2.6.5.1 United Kingdom Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.2.6.5.2 United Kingdom Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.2.6.5.3 United Kingdom Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Overview
10.3.2 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis
10.3.3 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Dosage Form
10.3.4 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Drug Release Mechanism
10.3.5 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Oral Solid Dosage Pharmaceutical Formulation Market
10.3.6.1.1 Australia Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.3.6.1.2 Australia Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.3.6.1.3 Australia Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.3.6.2 China Oral Solid Dosage Pharmaceutical Formulation Market
10.3.6.2.1 China Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.3.6.2.2 China Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.3.6.2.3 China Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.3.6.3 India Oral Solid Dosage Pharmaceutical Formulation Market
10.3.6.3.1 India Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.3.6.3.2 India Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.3.6.3.3 India Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.3.6.4 Japan Oral Solid Dosage Pharmaceutical Formulation Market
10.3.6.4.1 Japan Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.3.6.4.2 Japan Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.3.6.4.3 Japan Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.3.6.5 South Korea Oral Solid Dosage Pharmaceutical Formulation Market
10.3.6.5.1 South Korea Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.3.6.5.2 South Korea Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.3.6.5.3 South Korea Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Overview
10.4.2 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis
10.4.3 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Dosage Form
10.4.4 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Drug Release Mechanism
10.4.5 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Oral Solid Dosage Pharmaceutical Formulation Market
10.4.6.1.1 South Africa Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.4.6.1.2 South Africa Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.4.6.1.3 South Africa Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.4.6.2 Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Market
10.4.6.2.1 Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.4.6.2.2 Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.4.6.2.3 Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.4.6.3 U.A.E Oral Solid Dosage Pharmaceutical Formulation Market
10.4.6.3.1 U.A.E Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.4.6.3.2 U.A.E Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.4.6.3.3 U.A.E Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Oral Solid Dosage Pharmaceutical Formulation Market Overview
10.5.2 South and Central America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis
10.5.3 South and Central America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Dosage Form
10.5.4 South and Central America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Drug Release Mechanism
10.5.5 South and Central America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Oral Solid Dosage Pharmaceutical Formulation Market
10.5.6.1.1 Brazil Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.5.6.1.2 Brazil Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.5.6.1.3 Brazil Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.5.6.2 Argentina Oral Solid Dosage Pharmaceutical Formulation Market
10.5.6.2.1 Argentina Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.5.6.2.2 Argentina Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.5.6.2.3 Argentina Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKET, KEY COMPANY PROFILES
12.1. MERCK CO. And INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. NOVARTIS AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PFIZER INC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BAYER AG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ASTELLAS PHARMA INC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. TAKEDA PHARMACEUTICAL COMPANY LIMITED
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ASHLAND
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. CORDENPHARMA INTERNATIONAL
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ACME GENERICS LLP
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. COREALIS PHARMA INC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Oral Solid Dosage Pharmaceutical Formulation Market - By Dosage Form
1.3.2 Oral Solid Dosage Pharmaceutical Formulation Market - By Drug Release Mechanism
1.3.3 Oral Solid Dosage Pharmaceutical Formulation Market - By Distribution Channel
1.3.4 Oral Solid Dosage Pharmaceutical Formulation Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKET - GLOBAL MARKET ANALYSIS
6.1. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION - GLOBAL MARKET OVERVIEW
6.2. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKET - REVENUE AND FORECASTS TO 2027 - DOSAGE FORM
7.1. OVERVIEW
7.2. DOSAGE FORM MARKET FORECASTS AND ANALYSIS
7.3. TABLETS
7.3.1. Overview
7.3.2. Tablets Market Forecast and Analysis
7.4. CAPSULES
7.4.1. Overview
7.4.2. Capsules Market Forecast and Analysis
7.5. POWDERS
7.5.1. Overview
7.5.2. Powders Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKET - REVENUE AND FORECASTS TO 2027 - DRUG RELEASE MECHANISM
8.1. OVERVIEW
8.2. DRUG RELEASE MECHANISM MARKET FORECASTS AND ANALYSIS
8.3. IMMEDIATE RELEASE
8.3.1. Overview
8.3.2. Immediate Release Market Forecast and Analysis
8.4. EXTENDED RELEASE
8.4.1. Overview
8.4.2. Extended Release Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACY
9.3.1. Overview
9.3.2. Hospital Pharmacy Market Forecast and Analysis
9.4. RETAIL PHARMACY
9.4.1. Overview
9.4.2. Retail Pharmacy Market Forecast and Analysis
9.5. DRUG STORES
9.5.1. Overview
9.5.2. Drug Stores Market Forecast and Analysis
9.6. ONLINE PHARMACY.
9.6.1. Overview
9.6.2. Online Pharmacy. Market Forecast and Analysis
10. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Oral Solid Dosage Pharmaceutical Formulation Market Overview
10.1.2 North America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis
10.1.3 North America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Dosage Form
10.1.4 North America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Drug Release Mechanism
10.1.5 North America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Countries
10.1.6.1 United States Oral Solid Dosage Pharmaceutical Formulation Market
10.1.6.1.1 United States Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.1.6.1.2 United States Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.1.6.1.3 United States Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.1.6.2 Canada Oral Solid Dosage Pharmaceutical Formulation Market
10.1.6.2.1 Canada Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.1.6.2.2 Canada Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.1.6.2.3 Canada Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.1.6.3 Mexico Oral Solid Dosage Pharmaceutical Formulation Market
10.1.6.3.1 Mexico Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.1.6.3.2 Mexico Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.1.6.3.3 Mexico Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Oral Solid Dosage Pharmaceutical Formulation Market Overview
10.2.2 Europe Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis
10.2.3 Europe Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Dosage Form
10.2.4 Europe Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Drug Release Mechanism
10.2.5 Europe Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Oral Solid Dosage Pharmaceutical Formulation Market
10.2.6.1.1 Germany Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.2.6.1.2 Germany Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.2.6.1.3 Germany Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.2.6.2 France Oral Solid Dosage Pharmaceutical Formulation Market
10.2.6.2.1 France Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.2.6.2.2 France Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.2.6.2.3 France Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.2.6.3 Italy Oral Solid Dosage Pharmaceutical Formulation Market
10.2.6.3.1 Italy Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.2.6.3.2 Italy Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.2.6.3.3 Italy Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.2.6.4 Spain Oral Solid Dosage Pharmaceutical Formulation Market
10.2.6.4.1 Spain Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.2.6.4.2 Spain Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.2.6.4.3 Spain Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.2.6.5 United Kingdom Oral Solid Dosage Pharmaceutical Formulation Market
10.2.6.5.1 United Kingdom Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.2.6.5.2 United Kingdom Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.2.6.5.3 United Kingdom Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Overview
10.3.2 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis
10.3.3 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Dosage Form
10.3.4 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Drug Release Mechanism
10.3.5 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Oral Solid Dosage Pharmaceutical Formulation Market
10.3.6.1.1 Australia Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.3.6.1.2 Australia Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.3.6.1.3 Australia Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.3.6.2 China Oral Solid Dosage Pharmaceutical Formulation Market
10.3.6.2.1 China Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.3.6.2.2 China Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.3.6.2.3 China Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.3.6.3 India Oral Solid Dosage Pharmaceutical Formulation Market
10.3.6.3.1 India Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.3.6.3.2 India Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.3.6.3.3 India Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.3.6.4 Japan Oral Solid Dosage Pharmaceutical Formulation Market
10.3.6.4.1 Japan Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.3.6.4.2 Japan Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.3.6.4.3 Japan Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.3.6.5 South Korea Oral Solid Dosage Pharmaceutical Formulation Market
10.3.6.5.1 South Korea Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.3.6.5.2 South Korea Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.3.6.5.3 South Korea Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Overview
10.4.2 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis
10.4.3 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Dosage Form
10.4.4 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Drug Release Mechanism
10.4.5 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Oral Solid Dosage Pharmaceutical Formulation Market
10.4.6.1.1 South Africa Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.4.6.1.2 South Africa Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.4.6.1.3 South Africa Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.4.6.2 Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Market
10.4.6.2.1 Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.4.6.2.2 Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.4.6.2.3 Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.4.6.3 U.A.E Oral Solid Dosage Pharmaceutical Formulation Market
10.4.6.3.1 U.A.E Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.4.6.3.2 U.A.E Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.4.6.3.3 U.A.E Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Oral Solid Dosage Pharmaceutical Formulation Market Overview
10.5.2 South and Central America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis
10.5.3 South and Central America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Dosage Form
10.5.4 South and Central America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Drug Release Mechanism
10.5.5 South and Central America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Oral Solid Dosage Pharmaceutical Formulation Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Oral Solid Dosage Pharmaceutical Formulation Market
10.5.6.1.1 Brazil Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.5.6.1.2 Brazil Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.5.6.1.3 Brazil Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
10.5.6.2 Argentina Oral Solid Dosage Pharmaceutical Formulation Market
10.5.6.2.1 Argentina Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form
10.5.6.2.2 Argentina Oral Solid Dosage Pharmaceutical Formulation Market by Drug Release Mechanism
10.5.6.2.3 Argentina Oral Solid Dosage Pharmaceutical Formulation Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKET, KEY COMPANY PROFILES
12.1. MERCK CO. And INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. NOVARTIS AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PFIZER INC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BAYER AG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ASTELLAS PHARMA INC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. TAKEDA PHARMACEUTICAL COMPANY LIMITED
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ASHLAND
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. CORDENPHARMA INTERNATIONAL
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ACME GENERICS LLP
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. COREALIS PHARMA INC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Merck Co and Inc.
2. Novartis AG
3. Pfizer Inc
4. Bayer AG
5. Astellas Pharma Inc
6. Takeda Pharmaceutical Company Limited
7. Ashland
8. CordenPharma International
9. Acme Generics LLP
10. COREALIS Pharma Inc